Enterprise Value
298.6M
Cash
127.6M
Avg Qtr Burn
-35.24M
Short % of Float
30.76%
Insider Ownership
16.21%
Institutional Own.
52.29%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|